Literature DB >> 26419911

Is immune system-related hypertension associated with ovarian hormone deficiency?

Kathryn Sandberg1, Hong Ji1, Gillian Einstein2, April Au2, Meredith Hay3.   

Abstract

NEW
FINDINGS: What is the topic of this review? This review summarizes recent data on the role of ovarian hormones and sex in inflammation-related hypertension. What advances does it highlight? The adaptive immune system has recently been implicated in the development of hypertension in males but not in females. The role of the immune system in the development of hypertension in women and its relationship to ovarian hormone production are highlighted. The immune system is known to contribute to the development of high blood pressure in males. However, the role of the immune system in the development of high blood pressure in females and the role of ovarian hormones has only recently begun to be studied. In animal studies, both the sex of the host and the T cell are critical biological determinants of susceptibility and resistance to hypertension induced by angiotensin II. In women, natural menopause is known to result in significant changes in the expression of genes regulating the immune system. Likewise, in animal models, ovariectomy results in hypertension and an upregulation in T-cell tumour necrosis factor-α-related genes. Oestrogen replacement results in decreases in inflammatory genes in the brain regions involved in blood pressure regulation. Together, these studies suggest that the response of the adaptive immune system to ovarian hormone deficiency is a significant contributor to hypertension in women.
© 2015 The Authors. Experimental Physiology © 2015 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26419911      PMCID: PMC5380117          DOI: 10.1113/EP085149

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  37 in total

1.  Sex differences in the development of angiotensin II-induced hypertension in conscious mice.

Authors:  Baojian Xue; Jaya Pamidimukkala; Meredith Hay
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-12-30       Impact factor: 4.733

2.  The requirement of CD8+ T cells to initiate and augment acute cardiac inflammatory response to high blood pressure.

Authors:  Feifei Ma; Jin Feng; Chao Zhang; Yulin Li; Guanming Qi; Huihua Li; Yuzhang Wu; Yangxin Fu; Yang Zhao; Hairong Chen; Jie Du; Hong Tang
Journal:  J Immunol       Date:  2014-03-05       Impact factor: 5.422

3.  Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

Authors:  A Deswal; N J Petersen; A M Feldman; J B Young; B G White; D L Mann
Journal:  Circulation       Date:  2001-04-24       Impact factor: 29.690

4.  Genetic control of the CD4/CD8 T-cell ratio in humans.

Authors:  A Amadori; R Zamarchi; G De Silvestro; G Forza; G Cavatton; G A Danieli; M Clementi; L Chieco-Bianchi
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

Review 5.  Treating atherosclerosis with regulatory T cells.

Authors:  Amanda C Foks; Andrew H Lichtman; Johan Kuiper
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-20       Impact factor: 8.311

Review 6.  Sex-specific immune modulation of primary hypertension.

Authors:  Kathryn Sandberg; Hong Ji; Meredith Hay
Journal:  Cell Immunol       Date:  2014-12-08       Impact factor: 4.868

7.  Neuroprotective actions of selective estrogen receptor modulators.

Authors:  Lydia L DonCarlos; Iñigo Azcoitia; Luis M Garcia-Segura
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

8.  Hormone replacement therapy and inflammation: interactions in cardiovascular disease.

Authors:  Andrew P Miller; Yiu-Fai Chen; Dongqi Xing; Wenguang Feng; Suzanne Oparil
Journal:  Hypertension       Date:  2003-08-11       Impact factor: 10.190

Review 9.  Sex differences in angiotensin II- induced hypertension.

Authors:  B Xue; A K Johnson; M Hay
Journal:  Braz J Med Biol Res       Date:  2007-05       Impact factor: 2.590

Review 10.  Premature ovarian failure (POF): discordance between somatic and reproductive aging.

Authors:  Lubna Pal; Nanette Santoro
Journal:  Ageing Res Rev       Date:  2002-06       Impact factor: 10.895

View more
  3 in total

1.  Menopause and FOXP3+ Treg cell depletion eliminate female protection against T cell-mediated angiotensin II hypertension.

Authors:  Dennis P Pollow; Joshua A Uhlorn; Megan A Sylvester; Melissa J Romero-Aleshire; Jennifer L Uhrlaub; Merry L Lindsey; Janko Nikolich-Zugich; Heddwen L Brooks
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-17       Impact factor: 4.733

Review 2.  Hypertension in Women.

Authors:  Tatjana Tasić; Marijana Tadić; Maja Lozić
Journal:  Front Cardiovasc Med       Date:  2022-06-03

3.  Pre-Existing Hypertension Is Related with Disproportions in T-Lymphocytes in Older Age.

Authors:  Anna Tylutka; Barbara Morawin; Artur Gramacki; Agnieszka Zembron-Lacny
Journal:  J Clin Med       Date:  2022-01-06       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.